In addition, 30.2% n = 392 of the participants presented anti-HB antibodies titers resulting from vaccinations which were greater than or equal to 10 IU/L while 67.9% n = 882 had no serological markers identifable with the serological tests employed and were defined as susceptible Table 2.
Por otra parte, en 30,2% n= 392 se detectaron títulos de anticuerpos anti-HBs por vacunación igual o mayor a 10 UI/L y en 67,9% n= 882 no se identificaron marcadores serológicos con las pruebas serológicas empleadas, definidos como susceptibles tabla 2.